{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-055085","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2026-05-12T20:16:15+00:00","discovered_at":"2026-05-12T20:18:00.325646+00:00","generated_at":"2026-05-12T20:45:03.155362+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenon Medical Q1 2026 revenue $1.4M (+90% YoY), gross margin expands to 68.5%","bullets":["Revenue $1.4M, up ~90% YoY from $0.7M; gross profit $0.9M, up ~193% YoY.","Gross margin improved 24 percentage points to 68.5% from 44.5% in Q1 2025.","Net loss $3.5M ($0.31/share) vs $3.6M ($1.01/share); cash $4.6M at quarter end.","Closed $4.3M senior convertible note private placement to fund commercial expansion and development.","Post-quarter: opened Center of Excellence in Tampa, FL and expanded Eastern region sales leadership."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-055085","json":"https://secwatch.observer/filing/0001213900-26-055085.json","markdown":"https://secwatch.observer/filing/0001213900-26-055085.md","text":"https://secwatch.observer/filing/0001213900-26-055085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026055085/0001213900-26-055085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026055085/ea0290384-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T20:45:03.155362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81946a679cb3da78274bb85a437814e42c70e063","claim":"Tenon Medical, Inc. reported the first quarter ended March 31, 2026 results: revenue $1.4 million, net income $3.5 million, EPS $0.31 per share.","evidence_excerpt":"PRESS RELEASE OF TENON MEDICAL, INC., DATED MAY 12, 2026 Exhibit 99.1 Tenon® Medical Reports First Quarter 2026 Financial Results ~ First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~ ~ First Quarter Gross Profit of $0.9 Million, an Increase of Approximately 193% Compared to Prior Year ~ ~ Gross Margin","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026055085/0001213900-26-055085-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$1.4 million"},{"label":"Net income","value":"$3.5 million"},{"label":"EPS","value":"$0.31 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}